Preventive
PrivateLast Round
Seed
Oct 30, 2025
Total Funding Raised
$30M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Preventive is a biotechnology company that develops prenatal gene-editing technologies intended for the prevention of severe genetic conditions before birth.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Preventive Comparables
Compare Preventive with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Origin Genomics | 90% | |
| Bootstrap Bio, Inc. | 78% | |
| Prime Medicine | 66% |
Preventive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 30, 2025 |
Preventive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SciFounders | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2026
Grew 43% QoQ from 7 to 10 employees.
Preventive Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Preventive's valuation, stock price, and market status.
Is Preventive a public or private company?
Preventive is a private company.
What is the current stock price of Preventive?
Preventive is a private company, so its shares have no public market price. Caplight tracks Preventive's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Preventive worth (valuation)?
Valuation information for Preventive is not publicly available.
Can I buy Preventive stock?
Preventive shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Preventive's last funding round?
Preventive's most recent funding round was Seed on October 30, 2025.
Who are the main investors in Preventive?
Key investors in Preventive include SciFounders.
Will Preventive IPO soon?
No public IPO plans have been announced for Preventive.
How can I track Preventive secondary market activity?
Caplight tracks bids, offers, and trades in Preventive's shares on secondary markets.